key: cord-0763837-w1r0hzwt
authors: Alamar, Ihab; Abu-Arja, Mohammad H; Heyman, Taryn; Roberts, Drucilla J; Desai, Niyati; Narula, Pramod; Dygulska, Beata
title: A Possible Case of Vertical Transmission of SARS-CoV-2 in a Newborn with Positive Placental In Situ Hybridization of SARS-CoV-2 RNA
date: 2020-09-05
journal: J Pediatric Infect Dis Soc
DOI: 10.1093/jpids/piaa109
sha: 2aef4faccf0214d60e086b8c201f5e355da19a0f
doc_id: 763837
cord_uid: w1r0hzwt

Little is known about the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the coronavirus disease 2019 (COVID-19) on pregnant mothers and their infants. Moreover, there is no definitive evidence that SARS CoV- 2 can be vertically transmitted from an infected mother to the unborn fetus.

M a n u s c r i p t A c c e p t e d M a n u s c r i p t 5

An otherwise healthy, 32-year-old gravida 2 para 0 female presented at 35+6 gestational age with vaginal bleeding and contractions. She reported subjective fever, mild chills, fatigue, dysgeusia, and anosmia beginning 1 day before the presentation. Her prenatal care started in the first trimester; her perinatal serologies were not significant. A 2630 grams (56 th percentile) female was delivered via an urgent cesarean section due to bleeding secondary to placenta previa on April 7 th , 2020. The APGAR scores were 9 at both 1 and 5 minutes. The newborn displayed no signs of respiratory distress. The newborn length was 49.5 cm (89 th percentile), and occipitofrontal circumference was 35 cm (97 th percentile). The father had potential exposure as he works as a respiratory therapist at an intensive-care unit treating patients with COVID-19. However, the father was never symptomatic and was never tested before or during pregnancy. The maternal screen for SARS-CoV-2 nucleic acid from nasopharyngeal swab was positive on postpartum day 1.

The mother wore a surgical mask and a disposable, non-sterile isolation gown throughout her hospitalization. She washed her hands and chest with soap and water before breastfeeding or skin to skin care. The infant was kept inside a closed incubator, placed 6 feet away from the mother's bed in the same room. She fed her baby with formula and direct breastfeeding. On postpartum day 2, the mother started expressing her breast milk, and the nurse fed the baby. 

In this case, a neonate born to a mother with COVID-19 had positive nasopharyngeal qRT-PCR at 24, 48 HOL, and DOL 7. The infant remained afebrile and asymptomatic with normal hematologic and inflammatory markers. There was no evidence of growth restriction nor microcephaly. However, since the delivery time was close to the time of the maternal infection, we cannot rule out the risk of growth restriction and microcephaly in future cases.

Although the mother wore personal protective equipment, the infant was not isolated immediately after delivery. The baby started breastfeeding at 1 HOL, and the first neonate nasopharyngeal qRT-PCR was done at 24 HOL. Moreover, the mother breast milk was not tested for SARS-CoV-2. Therefore, the neonate positive nasopharyngeal qRT-PCR may be examined 16 placentas of mothers with SARS-CoV-2 [3] . They reported an increase in the rate of features of MVM and intervillous thrombi compared with historical controls [3] .

Intervillous thrombi and MVM are associated with maternal hypertensive disorders such as hypertension and pre-eclampsia. However, there was a negative association between preeclampsia and positive SARS-CoV-2 mothers in both Shanes et al. and Zhang et al. [1, 2] .

Therefore, more studies are needed to evaluate the relationship between MVM, placenta coagulopathies, and SARS-CoV-2.

A c c e p t e d M a n u s c r i p t [4] . However, the lack of the SARS-CoV-2 signal in the Hofbauer cells necessitates further exploration of the possibility of maternal histiocytes carrying SARS-CoV-2.

Our report is limited by including only one single case with no PCR testing of the amniotic fluid or maternal and newborn serum. Moreover, the mother started to have symptoms just one day before delivery. Therefore, the vertical transmission may suggest that the mother was viremic during her incubation period. However, no clinical testing capability was available for testing the SARS-CoV-2 viral load of the mother or fetus's blood. More A c c e p t e d M a n u s c r i p t 13 Figure 2 

Detection of SARS-CoV-2 in placentas with pathology and vertical transmission

SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers

Placental Pathology in COVID-19

Pathology of congenital Zika syndrome in Brazil: a case series

We would like to thank Dr. Peilin Zhang MD and Dr. Carolyn M. Salafia MD from the Department of Pathology of New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York for performing the pathological assessment of the placenta, performing the CD68 immunohistochemical assessment of the placenta, and critically reviewing the manuscript for important intellectual content.We would like to thank Dr. Vikram Deshpande MD, and Dr. David Ting MD for the Departments of Pathology and Internal Medicine, Massachusetts General Hospital, Boston MA for performing the placenta medical SARS-CoV-2 RNA ISH.

M a n u s c r i p t 9

All the authors have no financial relationships relevant to this article.

The authors have no conflicts of interest relevant to this article to disclose.A c c e p t e d M a n u s c r i p t 10